TP53 and adenocarcinoma: Patients in the p53-Ab (+) group more frequently had squamous cell cancer (21 patients [14.8%] vs 14 patients [5.6%]) and less frequently had adenocarcinoma (120 patients [84.5%] vs 232 patients [92.8%]) compared with those in the p53-Ab (−) group.